LFVN vs GANX
Comparison between Lifevantage Corporation (LFVN, Company) and Gain Therapeutics Inc (GANX, Company).
LFVN is from the Consumer Defensive sector, while GANX is from the Healthcare sector.
5-Year PerformanceLFVN has outperformed GANX, delivering a return of +0.2% compared to -27.0%
LFVN vs GANX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
LFVN vs GANX - Historical Returns
Returns include dividend reinvestment.
LFVN vs GANX - Annual Returns (2004 - 2026)
Returns include dividend reinvestment.
| Year | LFVN | GANX |
|---|---|---|
| 2026 | +7.93% | -40.88% |
| 2025 | -64.54% | +38.79% |
| 2024 | +202.41% | -40.41% |
| 2023 | +72.46% | +0.77% |
| 2022 | -43.01% | -42.46% |
| 2021 | -32.98% | -51.52% |
| 2020 | -39.56% | N/A |
| 2019 | +20.17% | N/A |
| 2018 | +174.79% | N/A |
| 2017 | -40.28% | N/A |
| 2016 | -13.21% | N/A |
| 2015 | +3.03% | N/A |
| 2014 | -21.21% | N/A |
| 2013 | -26.99% | N/A |
| 2012 | +59.85% | N/A |
| 2011 | +286.49% | N/A |
| 2010 | +50.00% | N/A |
| 2009 | +25.00% | N/A |
| 2008 | -9.09% | N/A |
| 2007 | -57.45% | N/A |
| 2006 | -78.00% | N/A |
| 2005 | -29.09% | N/A |
| 2004 | -17.42% | N/A |
LFVN vs GANX Drawdown Comparison
The maximum drawdown for LFVN was -99.57%, occurring on Nov 12, 2008. This drawdown has not yet recovered.
The maximum drawdown for GANX was -94.08%, occurring on Aug 13, 2024. This drawdown has not yet recovered.
The current LFVN drawdown is -93.40%. The current GANX drawdown is -88.10%.
| Rank | LFVN | GANX |
|---|---|---|
| #1 | -99.57% Jun 6, 2005 - Nov 12, 2008 | -94.08% Apr 5, 2021 - Aug 13, 2024 |
| #2 | -58.49% Feb 9, 2005 - Jun 2, 2005 | -7.95% Mar 22, 2021 - Mar 26, 2021 |
| #3 | -47.42% Oct 13, 2004 - Jan 28, 2005 | N/A |
| #4 | -25.58% Feb 1, 2005 - Feb 7, 2005 | N/A |
| #5 | -1.32% Oct 11, 2004 - Oct 13, 2004 | N/A |
Correlation
Correlation between LFVN and GANX is -0.24 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks